Baxa to Feature Exacta-Med® and Closed System Technology For Safe Handling and Administration of Fluid Drugs at the Pharmaceutical Marketing Congress in Philadelphia

Baxa Corporation is presenting systems designed to enhance the safety and efficiency of fluid medication delivery at the third annual Pharmaceutical Marketing Congress, Sept. 27-29, 2004, in Philadelphia. The congress brings together business development and marketing executives to focus on strategic alliances, patient education and compliance, and market development issues. Founded in 1975, Denver-based Baxa Corporation has built its reputation by designing niche products that provide solutions for the transfer, delivery, packaging and administration of fluid medications in hospital pharmacy and alternate-site settings worldwide.

Philadelphia, PA (PRWEB) September 27, 2004 -- At the third annual Pharmaceutical Marketing Congress, Baxa Corporation presents systems designed to enhance the safety and efficiency of fluid medication delivery. The Exacta-Med System provides oral and enteral medication delivery without risk of wrong-route administration. The system's non-luer components cannot actuate a needleless valve or connect to a hypodermic needle or fitting. Exacta-Med products offer added value to packaged pharmaceuticals as part of a complete drug delivery system.

The Pharmaceutical Marketing Congress, which continues through September 29th, brings together business development and marketing executives to focus on strategic alliances, patient education and compliance, and market development issues. This year is the first for Baxa Corporation's participation in the event. Baxa offers a dedication to safety and efficiency for fluid medication handling and delivery that provides manufacturers a way to ensure delivery accuracy and differentiation for their drug products. Healthcare professionals have recognized Baxa products for their quality and design for thirty years.

"With our participation in meetings such as this Congress, Baxa is looking for opportunities to help other manufacturers meet their goals - whether they are creating new opportunities for mature products, or looking for systems to improve the outcomes of clinical trials," affirms Steve Welch, VP of New Business Development. "With thirty years' experience, Baxa has the regulatory background and market knowledge to assist other companies in the development of specialized products for drug delivery applications, or as a partner to add value through improved patient safety and compliance."

Founded in 1975, Baxa Corporation built its reputation by designing niche products that provide solutions for the transfer, delivery, packaging and administration of fluid medications in hospital pharmacy and alternate-site settings worldwide. The company has achieved certification to the quality standards for ISO 13485 and EN46001.

About Baxa Corporation:

A leading provider of devices and systems for the preparation, handling, packaging, and administration of liquid medications, Baxa manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Headquartered in Englewood, Colorado, Baxa has subsidiaries and sales offices in Canada, the United Kingdom; Denmark, and Germany; and distribution partners worldwide. Further information is available at http://www.baxa.com

Click the following link to view a presentation by Jim Jorgenson "Using a Closed System Device to Reduce Occupational Exposure to Hazardous Drugs." Jorgenson is Director of Pharmacy for the Huntsman Cancer Institute and Associate Dean for Professional Affairs at the University of Utah:

http://www.isips.org/presentations/PhaSeal/player.html

Contacts:

Marian Robinson, Vice President, Marketing

Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157

Email: marian.robinson@baxa.com

Maggie Holben, Absolutely Public Relations

303.984.9801 or 303.669.3558

Email: maggie@absolutelypr.com

###